{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:38:00Z","timestamp":1769812680046,"version":"3.49.0"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/med.0b013e3283533955","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:03:57Z","timestamp":1377878637000},"page":"168-175","source":"Crossref","is-referenced-by-count":26,"title":["Role of mineralocorticoid receptor in insulin resistance"],"prefix":"10.1097","volume":"19","author":[{"given":"Rajesh","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail K.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20211004","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-5-20211004","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-5-20211004","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1681\/ASN.2009070737","article-title":"Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.","volume":"20","author":"Mehdi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R4-5-20211004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms.","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-5-20211004","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-5-20211004","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ajh\/7.4.314","article-title":"Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects.","volume":"7","author":"Licata","year":"1994","journal-title":"Am J Hypertens"},{"key":"R7-5-20211004","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2007-1088","article-title":"Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.","volume":"92","author":"Bentley-Lewis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-5-20211004","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.HYP.27.5.1180","article-title":"Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity.","volume":"27","author":"Ikeda","year":"1996","journal-title":"Hypertension"},{"key":"R9-5-20211004","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/hr.2009.220","article-title":"Effect of body weight loss and normalization on blood pressure in overweight nonobese patients with stage 1 hypertension.","volume":"33","author":"Fogari","year":"2010","journal-title":"Hypertens Res"},{"key":"R10-5-20211004","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1381\/0960892053923734","article-title":"Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.","volume":"15","author":"Ruano","year":"2005","journal-title":"Obes Surg"},{"key":"R11-5-20211004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.numecd.2008.06.001","article-title":"Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity.","volume":"19","author":"DallAsta","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R12-5-20211004","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0952-3278(99)80020-9","article-title":"Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans.","volume":"60","author":"Goodfriend","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R13-5-20211004","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1113\/expphysiol.2009.050997","article-title":"Sympathetic and haemodynamic responses to lipids in healthy human ageing.","volume":"95","author":"Florian","year":"2010","journal-title":"Exp Physiol"},{"key":"R14-5-20211004","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/HYPERTENSIONAHA.110.168872","article-title":"Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.","volume":"58","author":"Nguyen Dinh Cat","year":"2011","journal-title":"Hypertension"},{"key":"R15-5-20211004","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.jhh.1000642","article-title":"Insulin resistance in essential hypertension is related to plasma renin activity.","volume":"12","author":"Lind","year":"1998","journal-title":"J Hum Hypertens"},{"key":"R16-5-20211004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.25.1.30","article-title":"Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans.","volume":"25","author":"Goodfriend","year":"1995","journal-title":"Hypertension"},{"key":"R17-5-20211004","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc07-0525","article-title":"Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.","volume":"30","author":"Colussi","year":"2007","journal-title":"Diabetes Care"},{"key":"R18-5-20211004","first-page":"27","article-title":"Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertension.","volume":"6","author":"Lind","year":"1992","journal-title":"J Hum Hypertens"},{"key":"R19-5-20211004","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jc.2009-2521","article-title":"Aldosterone production and insulin resistance in healthy adults.","volume":"95","author":"Garg","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-5-20211004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jash.2011.09.005","article-title":". Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans.","volume":"6","author":"Huan","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"R21-5-20211004","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/HYPERTENSIONAHA.111.180521","article-title":"Plasma aldosterone levels and development of insulin resistance: prospective study in a general population.","volume":"58","author":"Kumagai","year":"2011","journal-title":"Hypertension"},{"key":"R22-5-20211004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11906-010-0126-2","article-title":"Mineralocorticoid receptor antagonists and the metabolic syndrome.","volume":"12","author":"Tirosh","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"R23-5-20211004","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"R24-5-20211004","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.107.708537","article-title":"Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.","volume":"116","author":"Ingelsson","year":"2007","journal-title":"Circulation"},{"key":"R25-5-20211004","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","article-title":"Association of adrenal steroids with hypertension and the metabolic syndrome in blacks.","volume":"49","author":"Kidambi","year":"2007","journal-title":"Hypertension"},{"key":"R26-5-20211004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1751-7176.2009.00084.x","article-title":"Hypertension, insulin resistance, and aldosterone: sex-specific relationships.","volume":"11","author":"Kidambi","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R27-5-20211004","doi-asserted-by":"crossref","first-page":"13219","DOI":"10.1073\/pnas.221467098","article-title":"Genetic variation in aldosterone synthase predicts plasma glucose levels.","volume":"98","author":"Ranade","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-5-20211004","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1440-1681.2011.05555.x","article-title":"Association of the aldosterone synthase gene-344TC polymorphism with essential hypertension and glucose homeostasis: a case-control study in a Han Chinese population.","volume":"38","author":"Li","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R29-5-20211004","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/ajh.2010.44","article-title":"Associations of the-344 TC and the 3097 GA polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population.","volume":"23","author":"Bellili","year":"2010","journal-title":"Am J Hypertens"},{"key":"R30-5-20211004","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/HJH.0b013e328336a090","article-title":"New evidence for the fetal insulin hypothesis: fetal angiotensinogen M235T polymorphism is associated with birth weight and elevated fetal total glycated hemoglobin at birth.","volume":"28","author":"Schlemm","year":"2010","journal-title":"J Hypertens"},{"key":"R31-5-20211004","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1210\/me.2010-0130","article-title":"Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivo.","volume":"24","author":"Bonzo","year":"2010","journal-title":"Mol Endocrinol"},{"key":"R32-5-20211004","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","article-title":"A possible association between primary aldosteronism and a lower beta-cell function.","volume":"25","author":"Mosso","year":"2007","journal-title":"J Hypertens"},{"key":"R33-5-20211004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"R34-5-20211004","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study.","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-5-20211004","first-page":"21","article-title":"Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment.","volume":"108","author":"Sindelka","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R36-5-20211004","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","article-title":"Adiponectin and insulin sensitivity in primary aldosteronism.","volume":"20","author":"Fallo","year":"2007","journal-title":"Am J Hypertens"},{"key":"R37-5-20211004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.numecd.2009.03.007","article-title":"Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.","volume":"20","author":"Ronconi","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R38-5-20211004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ajh.2009.206","article-title":"Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study.","volume":"23","author":"Fallo","year":"2010","journal-title":"Am J Hypertens"},{"key":"R39-5-20211004","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1470320311402110","article-title":"Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease.","volume":"12","author":"Polyzos","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R40-5-20211004","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.metabol.2010.09.005","article-title":"Low-salt diet increases insulin resistance in healthy subjects.","volume":"60","author":"Garg","year":"2011","journal-title":"Metabolism"},{"key":"R41-5-20211004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/CS20060361","article-title":"Salt intake and insulin sensitivity in healthy human volunteers.","volume":"113","author":"Townsend","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"R42-5-20211004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3945\/ajcn.2009.29028","article-title":"Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension.","volume":"92","author":"Yatabe","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"R44-5-20211004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.atherosclerosis.2007.12.034","article-title":"Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients.","volume":"200","author":"Nakandakare","year":"2008","journal-title":"Atherosclerosis"},{"key":"R45-5-20211004","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-7061(02)02952-7","article-title":"PAI-1 in human hypertension: relation to hypertensive groups.","volume":"15","author":"Srikumar","year":"2002","journal-title":"Am J Hypertens"},{"key":"R46-5-20211004","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1530\/EJE-11-0025","article-title":"The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.","volume":"164","author":"Vaidya","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R47-5-20211004","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1210\/jc.2006-2092","article-title":"Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men.","volume":"92","author":"Lely","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-5-20211004","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2337\/dc10-1723","article-title":"Dietary salt intake and mortality in patients with type 2 diabetes.","volume":"34","author":"Ekinci","year":"2011","journal-title":"Diabetes Care"},{"key":"R49-5-20211004","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/jama.2011.574","article-title":"Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion.","volume":"305","author":"Stolarz-Skrzypek","year":"2011","journal-title":"JAMA"},{"key":"R50-5-20211004","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc10-1722","article-title":"The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes.","volume":"34","author":"Thomas","year":"2011","journal-title":"Diabetes Care"},{"key":"R51-5-20211004","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ajh.2011.115","article-title":"Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review).","volume":"24","author":"Taylor","year":"2011","journal-title":"Am J Hypertens"},{"key":"R52-5-20211004","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIR.0b013e31820d0793","article-title":"The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association.","volume":"123","author":"Appel","year":"2011","journal-title":"Circulation"},{"key":"R53-5-20211004","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cbf.970","article-title":"Aldosterone impairs insulin responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor.","volume":"20","author":"Campion","year":"2002","journal-title":"Cell Biochem Funct"},{"key":"R54-5-20211004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0960-0760(99)00117-X","article-title":"Inhibition by aldosterone of insulin receptor mRNA levels and insulin binding in U-937 human promonocytic cells.","volume":"70","author":"Campion","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R55-5-20211004","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2008-1018","article-title":"Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes.","volume":"150","author":"Wada","year":"2009","journal-title":"Endocrinology"},{"key":"R56-5-20211004","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2005-870240","article-title":"Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes.","volume":"37","author":"Kraus","year":"2005","journal-title":"Horm Metab Res"},{"key":"R57-5-20211004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"R58-5-20211004","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells.","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"R59-5-20211004","first-page":"355","article-title":"The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation.","volume":"86","author":"Dandona","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R60-5-20211004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation.","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R61-5-20211004","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"R62-5-20211004","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0031-1277226","article-title":"Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes.","volume":"43","author":"Li","year":"2011","journal-title":"Horm Metab Res"},{"key":"R63-5-20211004","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1152\/ajpregu.91000.2008","article-title":"The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension.","volume":"298","author":"Ndisang","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R64-5-20211004","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1210\/en.2008-0239","article-title":"The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways.","volume":"150","author":"Ndisang","year":"2009","journal-title":"Endocrinology"},{"key":"R65-5-20211004","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat.","volume":"295","author":"Lastra","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R66-5-20211004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2009.06.030","article-title":"Impact of excess aldosterone on glucose homeostasis in adult male rat.","volume":"407","author":"Selvaraj","year":"2009","journal-title":"Clin Chim Acta"},{"key":"R67-5-20211004","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00004872-200109000-00009","article-title":"Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension.","volume":"19","author":"Atkins","year":"2001","journal-title":"J Hypertens"},{"key":"R68-5-20211004","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00125-011-2341-z","article-title":"Coupling factor 6-induced activation of ecto-F(1)F (o) complex induces insulin resistance, mild glucose intolerance and elevated blood pressure in mice.","volume":"55","author":"Osanai","year":"2012","journal-title":"Diabetologia"},{"key":"R69-5-20211004","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"R70-5-20211004","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s00125-011-2158-9","article-title":"Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets.","volume":"54","author":"Luther","year":"2011","journal-title":"Diabetologia"},{"key":"R71-5-20211004","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"R72-5-20211004","doi-asserted-by":"crossref","first-page":"F1013","DOI":"10.1152\/ajprenal.90646.2008","article-title":"Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.","volume":"296","author":"Whaley-Connell","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R73-5-20211004","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"R74-5-20211004","first-page":"45","article-title":"Eplerenone improves vascular function and reduces platelet activation in diabetic rats.","volume":"61","author":"Schafer","year":"2010","journal-title":"J Physiol Pharmacol"},{"key":"R75-5-20211004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.endonu.2011.09.003","article-title":"Plasma renin and aldosterone levels in obese and nonobese women with polycystic ovary syndrome.","volume":"59","author":"Mejia-Montilla","year":"2012","journal-title":"Endocrinol Nutr"},{"key":"R76-5-20211004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000201791","article-title":"Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.","volume":"32","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"R77-5-20211004","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1210\/jc.2008-2660","article-title":"Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.","volume":"94","author":"Menon","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R78-5-20211004","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events.","volume":"362","author":"McMurray","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201206000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T02:10:47Z","timestamp":1633313447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201206000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e3283533955","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}